IP Library Granted Patent US 8,617,589
Granted Patent B2
US 8,617,589 · App. 13/572,775 · Granted Dec 31, 2013

Biocompatible film with variable cross-sectional properties

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,589
App. No.
13/572,775
Granted
Dec 31, 2013
Kind
B2
Abstract

A biocompatible film includes a single layer having a plurality of components, at least one of the plurality of components having a predetermined non-uniform distribution in the thickness direction of the single layer. The at least one of the plurality of components that has a non-uniform distribution in the thickness direction of the single layer may have a substantially uniform distribution in the longitudinal and lateral directions of the single layer. The biocompatible film can be made by depositing a fluid composition including a film forming material and at least one other component immiscible with the film forming material and having a density different than the film forming material into a single layer, and drying the single layer such that the at least one other component has a predetermined non-uniform distribution in the thickness direction of the single layer after drying.

Claims (18)

1. A self-supporting biocompatible film comprising a single layer having a plurality of components, at least one of the plurality of components having a non-uniform distribution in the thickness direction of the single layer and a substantially uniform distribution in the longitudinal and lateral directions of the single layer;

wherein said self-supporting biocompatible film comprises a water soluble polymer, a water insoluble polymer, or a combination thereof.

2. The self-supporting biocompatible film according to claim 1 , wherein the plurality of components include a bioactive agent.

3. The self-supporting biocompatible film according to claim 2 , wherein the bioactive agent is present throughout the thickness of the single layer.

4. The self-supporting biocompatible film according to claim 3 , wherein the bioactive agent has a substantially uniform distribution in the thickness direction of the single layer.

5. The self-supporting biocompatible film according to claim 3 , wherein the bioactive agent has a substantially non-uniform distribution in the thickness direction of the single layer.

6. The self-supporting biocompatible film according to claim 2 , wherein the bioactive agent is at least one material selected from the group consisting of a pharmaceutical, a biological, an antigen, a confection, a food, a flavor, a vitamin, a botanical, a nutraceutical, a cosmaceutical, a protein and a genetic agent or modifier.

7. The self-supporting biocompatible film according to claim 2 , wherein a first bioactive agent is provided in one portion in the thickness direction of the single layer and a second bioactive agent is provided in another portion in the thickness direction of the single layer.

8. The self-supporting biocompatible film according to claim 2 , wherein the bioactive agent is insulin.

9. The self-supporting biocompatible film according to claim 2 , wherein the at least one component having the predetermined non-uniform distribution in the thickness direction of the single layer is a bioactive absorption enhancer.

10. The self-supporting biocompatible film according to claim 2 , wherein the at least one component having the predetermined non-uniform distribution in the thickness direction of the single layer is a hydrophobic material.

11. The self-supporting biocompatible film according to claim 2 , wherein the bioactive agent is selected from the group consisting of nicotine, tobacco and tobacco derived botanical agents.

12. A self-supporting biocompatible film dosage unit comprising a single layer having a plurality of components, at least one of the plurality of components having a nonuniform distribution in the thickness direction of the single layer and a substantially uniform distribution in the longitudinal and lateral directions of the single layer;

wherein said self-supporting biocompatible film dosage unit comprises a water soluble polymer, a water insoluble polymer, or a combination thereof.

13. The self-supporting biocompatible film according to claim 12 , wherein the plurality of components include a bioactive agent.

14. The self-supporting biocompatible film according to claim 13 , wherein the bioactive agent is present throughout the thickness of the single layer.

15. The self-supporting biocompatible film according to claim 14 , wherein the bioactive agent has a substantially uniform distribution in the thickness direction of the single layer.

16. The self-supporting biocompatible film according to claim 14 , wherein the bioactive agent has a substantially non-uniform distribution in the thickness direction of the single layer.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded May 13, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 075646/0258 →
SECURITY INTEREST Recorded May 12, 2026
From: AQUESTIVE THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 075561/0782 →
SECURITY INTEREST Recorded Nov 2, 2023
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065446/0494 →
RELEASE OF SECURITY INTEREST Recorded Nov 1, 2023
From: U.S. BANK TRUST COMPANY NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S BANK NATIONAL ASSOCIATION)
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 065426/0642 →
SECURITY INTEREST Recorded Jul 15, 2019
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 049758/0082 →
RELEASE OF SECURITY INTEREST Recorded Jul 15, 2019
From: PERCEPTIVE CREDIT HOLDINGS, LP
To: AQUESTIVE THERAPEUTICS, INC.; MONOSOL RX, INC.; MSRX US, LLC
Reel/Frame 049757/0733 →
AMENDMENT TO PATENT SECURITY AGREEMENT RECORDED AT REEL/FRAME 039707/0194 Recorded Jan 30, 2018
From: AQUESTIVE THERAPEUTICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 045279/0802 →
CHANGE OF NAME Recorded Jan 29, 2018
From: MONOSOL RX, LLC
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 045196/0389 →
SECURITY INTEREST Recorded Aug 16, 2016
From: MONOSOL RX, LLC; MONOSOL RX, INC.; MSRX US, LLC
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 039707/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2012
From: FUISZ, RICHARD C.; FUISZ, JOSEPH M.; FUISZ LLC; FUISZ PHARMA LLC
To: MONOSOL RX LLC
Reel/Frame 029456/0654 →